Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin. - Test2 - elhamkhani - TriplyDB

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

http://www.wikidata.org/entity/Q34000409

about

Identification of the Calmodulin-Binding Domains of Fas Death Receptor PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy.Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes.Recent advances in the regulation of cholangiocarcinoma growth Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma.α-Mangostin from Cratoxylum arborescens demonstrates apoptogenesis in MCF-7 with regulation of NF-κB and Hsp70 protein modulation in vitro, and tumor reduction in vivo.Involvement of NF-κB and HSP70 signaling pathways in the apoptosis of MDA-MB-231 cells induced by a prenylated xanthone compound, α-mangostin, from Cratoxylum arborescens Pathogenesis, diagnosis, and management of cholangiocarcinoma Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways.Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.Targeting the Fas/FasL signaling pathway in cancer therapy.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer Calmodulin as a potential target by which berberine induces cell cycle arrest in human hepatoma Bel7402 cells.Reduced CaM/FLIP binding by a single point mutation in c-FLIP(L) modulates Fas-mediated apoptosis and decreases tumorigenesis.Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK).Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.Animal models of cholangiocarcinoma.Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells.

P2860

Q28552166-B40EC5EC-D091-42C9-8EA5-0EF09E66FB77 Q33731141-D1A28219-97AE-4763-9434-F6EBE8747E75 Q33909909-D0FF74D9-8C2D-43E8-89FC-4B54A570BB76 Q33994814-27957CCE-10ED-4B79-B2F7-F2CEE8947904 Q34246496-0307E639-6B7F-4DC8-BBA0-3F8D9CE90E4E Q34306509-40C4ED06-426D-4777-8B18-A4560B265AC7 Q34489084-5FD971B5-77A6-4798-BD0D-151DA2642866 Q34656747-84C4CF99-1A0A-47E0-A98E-C566EA05F51E Q35190775-FF8EFB61-D700-4F45-BEF9-F679B8326EF1 Q35762274-8D7C8AB1-D931-45FE-964C-18EF06D274F1 Q37048442-C94A78D3-258D-41DC-9F24-512F84E4C565 Q37975245-004B7737-6395-4555-ABD6-46B9D7D6F14B Q38812588-8789EB07-63DA-4B3F-A27D-42001663B6E3 Q38839654-B907AF31-7BB7-43D9-B51E-D471B6F85196 Q39192041-1D02A937-7D38-49FA-BACA-141B17B95238 Q39474971-D7D7A6A8-2A22-4B7F-99E1-F4C616C11FE2 Q39536531-C3C94FB7-BF00-4A65-A118-544A1447F1A7 Q39564543-E5EBC4AC-C8EC-41B4-8EE9-B366D7E852B9 Q52720960-A742A759-706E-4507-96F9-791F95D26170 Q55387968-B3EBAC31-0C0D-4534-ACC7-C2E3D3CD5911

P2860

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

http://www.wikidata.org/entity/Q34000409

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

@ast

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

@en

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

@nl

type

label

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

@ast

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

@en

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

@nl

prefLabel

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

@ast

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

@en

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

@nl

P1433

Q34000409-ED102F8E-2ADC-4873-B9EC-1E70ABD4BEF1

P1476

Q34000409-551C59F9-1419-4A9E-8530-33D799419E83

P2093

Q34000409-0C57C0C9-8BE1-415A-86E9-C660666636B5

Q34000409-597D4604-2531-4CC6-8792-27F7B074F8F8

Q34000409-6234A5EC-C34B-4F9B-A998-FB70C6F325BC

Q34000409-659B6E3E-04F8-4149-B286-63FBD99D94CE

Q34000409-72BFF958-BE27-4238-8141-6C88C7267E69

Q34000409-816DB340-7C7E-401E-AA98-5F9F7A98E04D

Q34000409-9A82EF78-0508-4A58-9C71-0B6906E1479F

Q34000409-B186C6AD-0F5A-44DA-B122-A8A73A5A0618

Q34000409-FE22E402-39C7-449E-B411-E4BD1BB8D691

P2860

Q34000409-15B51B7E-2393-4632-8B88-B37E28EED327

Q34000409-15DF44FE-0A9B-4BD8-908C-262C9087E992

Q34000409-3339FAAD-AE68-43BF-9AFF-B64946667E66

Q34000409-39813733-786F-49F5-AFC6-553C29AB2721

Q34000409-4D53FD98-4764-4519-B0DA-C111AB90FB8C

Q34000409-4E22C985-5E70-41B8-B46A-9FE68232BC9B

Q34000409-50A944F8-6A8C-418A-BC82-FC28574B10AC

Q34000409-53EAF731-C84E-4814-BE38-AA011B73B0E1

Q34000409-57626497-4257-43D5-9736-CDC3E0010FD0

Q34000409-6F362171-1043-48AF-8D64-1DB98691782D

P304

Q34000409-37BDAE07-65BB-4F3F-A590-BE61E5045E95

P31

Q34000409-DEA1A85E-26F7-43A4-B798-BFCB3D3C6A50

P356

Q34000409-DAF91CCA-FE57-4C34-92BD-00DBDFED4003

P407

Q34000409-8D209B82-CCE3-48BA-8CC0-22E5C7BC38FA

P433

Q34000409-721EA45C-1BF7-4063-AD77-CB479D974334

P478

Q34000409-369885AA-9305-4DD5-B113-05A10B996CEC

P577

Q34000409-6C1BCC68-2537-4DC5-8380-A7A1F7EBB0B7

P5875

Q34000409-08F0AE27-EAA4-4797-A15B-183ABCB6FFA6

P698

Q34000409-C0618610-9CCA-4CB2-A559-CF21F0CBE209

P921

Q34000409-B69C5A6B-D327-46B9-B0C0-B98A5D45B66F

P932

Q34000409-C1ACDD97-964B-4FCF-BF54-BAA115511AE4

P356

1078-0432.CCR-08-1150

P1433

Clinical Cancer Research

P1476

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

@en

P2093

Chang Hyun Byon

http://www.w3.org/2001/XMLSchema#string

Eun-Young Ahn

http://www.w3.org/2001/XMLSchema#string

Hui Liu

http://www.w3.org/2001/XMLSchema#string

Jay M McDonald

http://www.w3.org/2001/XMLSchema#string

Juan P Arnoletti

http://www.w3.org/2001/XMLSchema#string

Liping Ma

http://www.w3.org/2001/XMLSchema#string

Nirag Jhala

http://www.w3.org/2001/XMLSchema#string

Pritish Pawar

http://www.w3.org/2001/XMLSchema#string

Yabing Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Calmodulin binding to the Fas death domain. Regulation by Fas activation

A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474

Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels

Calmodulin: a prototypical calcium sensor

CaM-kinases: modulators of synaptic plasticity

AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation

Sequence motifs for calmodulin recognition

The role of c-FLIP in modulation of CD95-induced apoptosis

The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase

P304

1288-1296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-08-1150

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24026625

http://www.w3.org/2001/XMLSchema#string

P698

19228732

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

2905314

http://www.w3.org/2001/XMLSchema#string